...BioMerge bioinformatics software. The technology will support GENZ’s Multiple Allele-Specific Diagnostic Assay (MASDA) technology and Genzyme Molecular Oncology...

...Gail Maderis as president and CEO, formerly corporate VP of Genzyme Corp. and president of Genzyme Molecular Oncology...

...GENZ anticipates that SANG's polyclonal group will work with the antigen discovery group from its Genzyme Molecular Oncology...

...Genzyme Biosurgery (GZBX), Cambridge, Mass. Genzyme Corp. , Cambridge, Mass. Genzyme General (GENZ), Cambridge, Mass. Genzyme Molecular Oncology...

...its would abandon the company's tracking stock structure, and that GENZ would acquire GZBX and Genzyme Molecular Oncology...

...the elimination of the company's tracking stock structure, and that GENZ would acquire GZBX and Genzyme Molecular Oncology...

...were tested. Data were presented at the American Society of Clinical Oncology meeting in Chicago. Genzyme Molecular Oncology...

...the elimination of the company's tracking stock structure, and that GENZ would acquire GZBX and Genzyme Molecular Oncology...

...Genzyme Biosurgery (GZBX), Cambridge, Mass. Genzyme Corp. , Cambridge, Mass. Genzyme General (GENZ), Cambridge, Mass. Genzyme Molecular Oncology...

...tracking stock structure. As a result, GENZ will acquire Genzyme Biosurgery (GZBX, Cambridge, Mass.) and Genzyme Molecular Oncology...